MedPage Today on MSN
GLP-1 drugs tied to mortality reduction in colon cancer patients with obesity
SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...
Newcastle University researchers discover exercise rapidly alters blood chemistry to support DNA repair in colon cancer cells ...
Just 10 minutes of intense exercise triggered surprising changes in colon cancer cells in a new study. Here’s what that may ...
Hosted on MSN
Colon cancer: Study links marathon running to increased risk of colorectal cancer; what you should be careful about
Thinking of hitting the sidewalk this weekend for a marathon? Hold on before you tie up your running shoes, and read this first. A new study from the Inova Schar Cancer Institute has raised eyebrows ...
Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.
In a retrospective study, patients with prior use of GLP-1 receptor agonists showed a significantly lower risk of developing ...
The Root on MSN
New Study Reveals A Possible Cause For The Rise Of Colorectal Cancer In Young Black Americans
When you narrow the numbers further, the risk for young Black Americans is even more severe. The American Cancer Society ...
1don MSN
INTERVIEW: Hartford HealthCare doctor on early colon cancer sign young people should be aware of
Many people associate colon cancer with old age, but that’s not the case anymore. New research is shedding light on a warning ...
We run for so many reasons, but a main one: It’s simply good for us. Running, and exercise in general, has been shown in study after study to protect against all kinds of chronic disease, including ...
A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...
A recent study revealed that GLP-1 drugs, Ozempic and Wegovy, primarily used for diabetes and weight loss, may assist in ...
5don MSN
Microbially produced secondary bile acids accelerate colorectal cancer development, study shows
For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback